Navneet Singh

Molecular Testing Guideline for the Selection of Patients With Lung Cancer for Treatment With Targeted Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Clinical Practice Guideline Update

Gregory P. Kalemkerian, Navneet Narula, Erin B. Kennedy et al. · Journal of Clinical Oncology · 2018 · 488 citations

Medicine, Oncology, Pathology +17

Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update

Nasser H. Hanna, Bryan J. Schneider, Sarah Temin et al. · Journal of Clinical Oncology · 2020 · 455 citations

Medicine, Oncology, Pharmacotherapy +16

Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline Update

Nasser H. Hanna, Andrew Robinson, Sarah Temin et al. · Journal of Clinical Oncology · 2021 · 301 citations

Medicine, Oncology, Cancer Genetics +11

The effect of intravenous interleukin-1 receptor antagonist on inflammatory mediators in cerebrospinal fluid after subarachnoid haemorrhage: a phase II randomised controlled trial

Navneet Singh, Stephen J. Hopkins, Sharon Hulme et al. · Journal of Neuroinflammation · 2014 · 288 citations · Full text

Medicine, Neurology, Neurosurgery +17

Lung Cancer Surveillance After Definitive Curative-Intent Therapy: ASCO Guideline

Bryan J. Schneider, Nofisat Ismaila, Joachim G.J.V. Aerts et al. · Journal of Clinical Oncology · 2019 · 193 citations

Medicine, Oncology, Radiation Oncology +17